Skip to main content
. 2018 Sep 12;13(9):e0203918. doi: 10.1371/journal.pone.0203918

Table 1. Characteristics of the study population by PPI exposure.

Exposure level to PPI (%)
Total cohort None <60 DDDs ≥60 DDDs
% (N = 453,611) (n = 403,826) (n = 44,075) (n = 5,710)
Age, years
40–49 48.3 48.6 46.5 37.4
50–59 28.1 27.9 30.3 32.1
≥60 23.6 23.5 23.2 30.6
Gender, male 53.5 53.4 53.6 58.6
Body mass index, kg/m2
<25.0 65.1 65.1 65.3 62.3
25.0–29.9 32.0 32.0 32.2 34.8
≥30.0 2.9 2.9 2.5 2.9
Smoking status
Never 69.5 69.6 69.4 66.8
Former 8.6 8.5 9.4 10.1
Current 20.6 20.7 20.3 22.3
Alcohol consumption, drinks/week
None 72.7 72.7 73.1 73.0
1–2 16.2 16.3 15.7 15.2
≥3 10.5 10.5 10.7 11.1
Physical activity, times/week
None 52.5 52.5 52.0 53.0
1–2 25.4 25.4 25.5 23.9
≥3 21.3 21.2 21.9 22.2
Type 2 diabetes 10.7 10.7 10.8 13.6
Chronic pancreatitis 0.3 0.2 0.5 0.9
CCI* score
0 29.2 32.2 5.7 3.1
1–2 54.5 53.1 67.1 61.1
≥3 16.2 14.8 27.2 35.8
SES, low 55.6 55.8 53.8 54.8

PPI, proton pump inhibitor; CCI, Charlson Comorbidity Index; SES, socioeconomic status.

*Including acute myocardial infarction, congestive heart failure, peripheral vascular disease, cerebral vascular accident, dementia, pulmonary disease, connective tissue disorder, peptic ulcer, liver disease, paraplegia, renal disease, severe liver disease, and HIV infection based on ICD-10 codes of hospital visits during years 2002 through 2006.

By quartiles of insurance premium (Q1–2).